Transition of Care for Inpatient Hematology Patients Receiving Chemotherapy: Development of Hospital Discharge Huddle Process and Effects of Implementation

J Oncol Pract. 2016 Jan;12(1):e88-94. doi: 10.1200/JOP.2015.005785. Epub 2015 Sep 15.

Abstract

Purpose: To develop a care model to decrease incidence of preventable errors in the complex multidisciplinary care of hematology inpatients at the time of discharge.

Methods: An interactive, multidisciplinary, structured discharge process was developed. Multiple focus groups were held to establish the strengths and gaps. A checklist was created for common follow-up needs. Outcomes measured included: dexamethasone received at discharge, antiemetics prescribed, hospital readmissions, number of patient telephone calls received postdischarge, chemotherapy letters created, pegfilgrastim arranged, and peripherally inserted catheter care arranged. Using a pre-post study design, we compared outcomes of patients after the checklist was implemented in June 2014 (n = 41) with a historical cohort of patients admitted to hematology for chemotherapy 1 year earlier in June 2013 (n = 42).

Results: Compared with the historical data, improvement was noted for all checklist items except number of hospital readmissions and number of nursing telephone calls. In June 2014, 100% of patients received pegfilgrastim, compared with 88% in June 2013 (P = .02). Antiemetic prescriptions after chemotherapy improved from 40% (June 2013) to 70% (June 2014; P = .004). Two areas did not show improvement: number of readmissions (12 v 21; P = .26) and number of telephone calls after discharge (nine each for June 2013 and 2014; P = 1.0).

Conclusion: There was significant decrease in preventable errors demonstrated after implementation of our care model. Developing a systematic approach to hospital discharges can lead to improvements and serve a model for other inpatient wards.

MeSH terms

  • Antineoplastic Agents* / therapeutic use
  • Checklist
  • Continuity of Patient Care
  • Hematologic Neoplasms* / therapy
  • Humans
  • Inpatients*
  • Models, Theoretical
  • Patient Discharge*
  • Patient Transfer*
  • Quality Improvement
  • Quality of Health Care
  • Workflow

Substances

  • Antineoplastic Agents